Robert Bodén

Depression

Bipolar disorder

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: A review

Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period

The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

Classification of suicide attempters in schizophrenia using sociocultural and clinical features: A machine learning approach

A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models

Effects of perinatal mental disorders on the fetus and child

Managing Your Own Mood Lability: Use of Mood Stabilizers and Antipsychotics in Pregnancy

2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Pregnancy Outcome Following In Utero Exposure to Lithium: A Prospective, Comparative, Observational Study

Barriers, Benefits, and Strategies for Physical Activity in Patients With Schizophrenia

The Social Determinants of Refugee Mental Health in the Post-Migration Context: A Critical Review

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Prognostic Factors in First-Episode Schizophrenia : Five-year Outcome of Symptoms, Function and Obesity

Biochemical risk factors for development of obesity in first-episode schizophrenia

A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice

Association between symptomatic remission and functional outcome in first-episode schizophrenia

Suicide in first episode psychosis: A nationwide cohort study

Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study

Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial